CN Patent

CN115154440A — 含右美托咪定的膜制剂及其制造方法

Assigned to Alces Co ltd · Expires 2022-10-11 · 4y expired

What this patent protects

本发明涉及含右美托咪定的膜制剂及其制造方法。本文公开了一种含有右美托咪定或其药学上可接受的盐的自支撑式可溶性膜。所述膜经口施用以通过透粘膜递送活性剂来治疗各种疾患，特别是激越。

USPTO Abstract

本发明涉及含右美托咪定的膜制剂及其制造方法。本文公开了一种含有右美托咪定或其药学上可接受的盐的自支撑式可溶性膜。所述膜经口施用以通过透粘膜递送活性剂来治疗各种疾患，特别是激越。

Drugs covered by this patent

chembl-chembl2106195 (DEXMEDETOMIDINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN115154440A
Jurisdiction: CN
Classification: —
Expires: 2022-10-11
Drug substance claim: No
Drug product claim: No
Assignee: Alces Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.